ClinicalTrials.Veeva

Menu

Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Diabetes Mellitus
Pregnancy

Study type

Observational

Funder types

Other

Identifiers

NCT01845324
0011-13

Details and patient eligibility

About

The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigators will measure the septum width in patients with Diabetes and will correlate to standard measurements of the glucuse levels.

Full description

In this study the investigators will follow patients with Diabetes Mellitus - mainly gestational. the investigators will measure the width of the interventricular septum and correlate with conventional measures of blood glucose measurements in this population.

The investigators will try to assess whether measurement of the septum can be an earlier and better predictor of glucose control in this population.

Enrollment

300 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All consequtive pregnant women
  • with Diabetes Mellitus - Gestational and non Gestational

Exclusion criteria

.No willing to participate.

  • Suspected Heart anomaly

Trial design

300 participants in 1 patient group

Diabetes Mellitus in pregnancy
Description:
Our cohort will include all consequtive women with Diabetes Mellitus atending our clinic

Trial contacts and locations

1

Loading...

Central trial contact

Alon Shrim, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems